Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970814 · ClinicalTrials.gov registry record · Phase 2
Levetiracetam XR in Very Heavy Drinkers
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 130
- Enrollment target
NCT00970814 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 130 participants.
The verdict
NCT00970814, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 130 participants
- Enrollment target
Study Summary
The primary objectives of this study are to assess the efficacy of levetiracetam XR in increasing the percentage of subjects with no heavy drinking days and in reducing the weekly percentage of heavy drinking days in subjects with alcohol dependence confirmed by DSM-IV criteria and who frequently consume 10 or more drinks per drinking day for men and 8 or more drinks per drinking day for women (designated as "very heavy" drinkers).
Interventions
- DRUG Sugar Pill
- BEHAVIORAL BBCET
- DRUG Levetiracetam XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00970814
The ClinicalTrials.gov registry entry for NCT00970814 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sugar Pill is the first listed.
NCT00970814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00970814 about?
NCT00970814 is a clinical study titled "Levetiracetam XR in Very Heavy Drinkers". The primary objectives of this study are to assess the efficacy of levetiracetam XR in increasing the percentage of subjects with no heavy drinking days and in reducing the weekly percentage of heavy drinking days in subjects with alcohol dependence confirmed by DSM-IV criteria and who frequently co...
What is the current status of trial NCT00970814?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2009-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00970814?
The interventions under investigation include: Sugar Pill (DRUG), BBCET (BEHAVIORAL), Levetiracetam XR (DRUG).
Who is sponsoring clinical trial NCT00970814?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.